Valuation: Giant Biogene Holding Co., Ltd.

Capitalization 55.27B 59.08B 7.58B 7.33B 6.9B 6.12B 10.86B 665B 12.11B 82.91B 30.81B 273B 28.43B 27.86B 1,147B P/E ratio 2024 *
27.4x
P/E ratio 2025 * 21.6x
Enterprise value 51.04B 54.56B 7B 6.77B 6.37B 5.65B 10.03B 614B 11.18B 76.57B 28.45B 252B 26.26B 25.72B 1,059B EV / Sales 2024 *
9.83x
EV / Sales 2025 * 7.27x
Free-Float
42.68%
Yield 2024 *
1.11%
Yield 2025 * 1.39%
More valuation ratios * Estimated data
Dynamic Chart
1 day+1.31%
1 week+0.35%
Current month+0.35%
1 month+24.41%
3 months+3.57%
6 months+39.00%
Current year+16.43%
More quotes
1 week
55.60
Extreme 55.6
59.60
1 month
45.50
Extreme 45.5
59.60
Current year
45.20
Extreme 45.2
59.60
1 year
33.15
Extreme 33.15
59.60
3 years
24.30
Extreme 24.3
59.60
5 years
24.30
Extreme 24.3
59.60
10 years
24.30
Extreme 24.3
59.60
More quotes
Director TitleAgeSince
Chief Executive Officer 58 2022-04-20
Director of Finance/CFO 38 2022-04-20
Corporate Secretary 29 2018-09-30
Manager TitleAgeSince
Chairman 58 2022-04-20
Director/Board Member 54 2021-11-29
Director/Board Member 66 2022-04-20
More insiders
Add to a list
Change 5d. change 1-year change 3-years change Capi.($)
+1.31%+0.35%+76.86% - 7.58B
-0.54%+1.19%+5.56%+4.77% 394B
+0.69%+1.42%+20.42%+21.76% 144B
+1.26%+0.07%+3.46%+6.95% 70.88B
-0.37%-4.25%-2.54%+4.71% 63.34B
+1.92%-5.21%-1.66% - 38.69B
-0.20%-1.98%-10.32%+44.03% 29.31B
+1.20%-22.05%-54.18%-79.32% 23.39B
+0.69%-0.61%+16.72%+7.10% 17.71B
-1.15%-1.29%-10.60%+24.44% 12.91B
Average +0.55%-3.85%+4.37%+4.30% 80.19B
Weighted average by Cap. +0.40%-1.15%+5.40%+7.52%
See all sector performances

Financials

2024 *2025 *
Net sales 5.19B 5.55B 712M 689M 647M 574M 1.02B 62.44B 1.14B 7.79B 2.89B 25.62B 2.67B 2.62B 108B 6.81B 7.28B 934M 903M 849M 753M 1.34B 81.92B 1.49B 10.21B 3.8B 33.61B 3.5B 3.43B 141B
Net income 2.01B 2.14B 275M 266M 250M 222M 394M 24.14B 439M 3.01B 1.12B 9.9B 1.03B 1.01B 41.62B 2.56B 2.73B 351M 339M 319M 283M 502M 30.75B 560M 3.83B 1.42B 12.62B 1.31B 1.29B 53.03B
Net Debt -4.23B -4.52B -581M -561M -528M -468M -831M -50.92B -927M -6.35B -2.36B -20.89B -2.18B -2.13B -87.8B -5.74B -6.13B -787M -761M -716M -635M -1.13B -69.01B -1.26B -8.6B -3.2B -28.32B -2.95B -2.89B -119B
More financial data * Estimated data
Logo Giant Biogene Holding Co., Ltd.
Giant Biogene Holding Co Ltd is a China-based investment holding company. The Company is principally engaged the research, development, manufacture and sale of bioactive material-based beauty and health products through its subsidiaries. The Company's main products include functional skincare products and medical dressings, and they are produced with recombinant collagen as the key bioactive ingredient. The Company also develops and manufactures rare ginsenosides technology-based functional foods. The Company mainly conducts its businesses within the domestic market.
Employees
1,512
More about the company
Date Price Change Volume
25-02-07 58.10 $ +1.31% 3,217,431
25-02-06 57.35 $ -1.12% 1,544,008
25-02-05 58.00 $ +0.35% 2,780,371
25-02-04 57.80 $ +1.67% 1,734,070

Delayed Quote Hong Kong S.E., February 07, 2025 at 03:08 am EST

More quotes
Trading Rating
Investor Rating
ESG MSCI
BB
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
21
Last Close Price
58.10HKD
Average target price
64.44HKD
Spread / Average Target
+10.91%
Consensus

Quarterly revenue - Rate of surprise